Total Visits

Views
Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial53

Select a period of time:

Views

Views
September 20251
October 20252
November 20250
December 20251
January 20261
February 20260
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United Kingdom3
Argentina1
United States1
 

Top cities views

Views
Buenos Aires1